ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,257.73
-0.87%
S&P 500
5,464.62
-0.16%
Dow Jones
39,150.33
0.04%
US Dollar vs Yen
159.605
0.43%
Brent Oil
84.43
-0.68%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Innovate Biopharmaceuticals Inc (INNT)

  7. Innovate Biopharmaceuticals Inc (INNT) ニュース

INNT

Innovate Biopharmaceutic... (INNT)

Innovate Biopharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:INNT
日付受信時刻ニュースソース見出しコード企業名
2019/11/1322 : 00PR Newswire (US)RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/11/0906 : 14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/11/0806 : 46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/10/0720 : 00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/08/2807 : 41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/08/2807 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/08/1322 : 00GlobeNewswire Inc.Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/08/0905 : 43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/08/0905 : 36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/08/0905 : 30GlobeNewswire Inc.Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate UpdatesNASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/07/1606 : 30GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings ReleaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/07/1519 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/07/0406 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/07/0406 : 04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/07/0406 : 03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/07/0206 : 00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/2806 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/2420 : 00GlobeNewswire Inc.Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial OfficerNASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/1106 : 04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/1021 : 01GlobeNewswire Inc.Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac DiseaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/0508 : 26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/0506 : 32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/0506 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/0321 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/0106 : 03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/06/0105 : 05Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/05/2905 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/05/2321 : 45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/05/2022 : 45GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...NASDAQ:INNTInnovate Biopharmaceuticals Inc
2019/05/1805 : 54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INNT

最近閲覧した銘柄

NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
PM
XAUUSD
Gold vs US Dollar
NYSE
KO
Coca Cola
NASDAQ
NVDA
NVIDIA
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
CVX
Chevron
CCOM
US500
US 500
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
FX
USDGBP
US Dollar vs Sterling
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有